Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in increased expression of RIPK2 mRNA | increases expression | 18648102
|
C010643 |
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid |
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Cholesterol analog results in increased expression of RIPK2 mRNA] | decreases reaction|increases expression | 19477266
|
D000111 |
Acetylcysteine |
Acetylcysteine inhibits the reaction [Cholesterol analog results in increased expression of RIPK2 mRNA] | decreases reaction|increases expression | 19477266
|
D001374 |
Azacitidine |
Azacitidine results in increased expression of RIPK2 mRNA | increases expression | 15547111
|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of RIPK2 mRNA | decreases expression | 20678512
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of RIPK2 mRNA | increases expression | 15336504
|
D002784 |
Cholesterol |
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Cholesterol analog results in increased expression of RIPK2 mRNA] | decreases reaction|increases expression | 19477266
|
D002784 |
Cholesterol |
Acetylcysteine inhibits the reaction [Cholesterol analog results in increased expression of RIPK2 mRNA] | decreases reaction|increases expression | 19477266
|
D002784 |
Cholesterol |
Cholesterol analog results in increased expression of RIPK2 mRNA | increases expression | 19477266
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of RIPK2 mRNA | increases expression | 20106945
|
D019259 |
Lamivudine |
[Zidovudine co-treated with Lamivudine] results in increased expression of RIPK2 mRNA | affects cotreatment|increases expression | 15784690
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of RIPK2 mRNA | increases expression | 16002434
|
D004317 |
Doxorubicin |
RIPK2 protein affects the susceptibility to Doxorubicin | affects response to substance | 16217747
|
D004391 |
Dust |
Dust results in increased expression of RIPK2 mRNA | increases expression | 17805423
|
D004958 |
Estradiol |
Estradiol affects the expression of RIPK2 mRNA | affects expression | 14699072
|
D004958 |
Estradiol |
Estradiol inhibits the reaction [Etoposide results in increased expression of RIPK2 mRNA] | decreases reaction|increases expression | 19426747
|
D005047 |
Etoposide |
Estradiol inhibits the reaction [Etoposide results in increased expression of RIPK2 mRNA] | decreases reaction|increases expression | 19426747
|
D005047 |
Etoposide |
Etoposide results in increased expression of RIPK2 mRNA | increases expression | 19426747
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of RIPK2 mRNA | increases expression | 20423518
|
D008070 |
Lipopolysaccharides |
phenethyl isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased expression of RIPK2 mRNA] | decreases reaction|increases expression | 20423518
|
C058305 |
phenethyl isothiocyanate |
phenethyl isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased expression of RIPK2 mRNA] | decreases reaction|increases expression | 20423518
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of RIPK2 mRNA | affects binding|increases activity|increases expression | 19710929
|
D019772 |
Topotecan |
RIPK2 protein affects the susceptibility to Topotecan | affects response to substance | 16217747
|
D015215 |
Zidovudine |
[Zidovudine co-treated with Lamivudine] results in increased expression of RIPK2 mRNA | affects cotreatment|increases expression | 15784690
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000163 |
Acquired Immunodeficiency Syndrome |
|
Zidovudine |
4.76 | 9612607 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
8.83 | 11850527 18653653 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
8.83 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
4.44 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.44 | 11473722 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
2.71 | 3712494 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.42 | 16434500 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.48 | 21441931 |
MESH:D050197 |
Atherosclerosis |
|
Cholesterol |
4.20 | 16632123 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.96 | 1440618 11289319 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.08 | 19483382 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
11.97 | 14601052 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Etoposide |
11.97 | 14601052 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.80 | 11985600 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.75 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
2.34 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
2.34 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.34 | 18628466 17983394 18234424 15668708 16264153 16935488 18695136 15994142 15939500 16115903 19526202 15993339 16096432 16595493 17369602 18382427 15634643 11325840 15692762 15567936 16826403 17426702 16322301 15136595 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.34 | 12948864 14630087 17261762 16675129 17289903 18497071 19861407 17018787 |
MESH:D001943 |
Breast Neoplasms |
|
Etoposide |
2.34 | 16322251 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.40 | 16111702 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.75 | 16051944 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
4.56 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
4.56 | 16234567 17876044 16023760 18059187 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
4.56 | 16924424 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.93 | 17123778 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
6.45 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
6.45 | 16201981 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Acetylcysteine |
7.64 | 17015178 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
7.64 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
7.64 | 6189445 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.48 | 16109756 17308081 17974986 16364871 15792986 17131338 16455267 15476868 17928571 16731534 15505089 17329180 17351982 17519947 16269455 16651473 16242529 16952015 16278810 17924179 17382496 15811867 17007740 16612575 18627295 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.92 | 16243910 17334414 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
15.68 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Acetylcysteine |
15.68 | 18226522 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
15.68 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
15.68 | 18566989 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
13.09 | 19486331 9022650 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
13.09 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
13.09 | 19176532 |
MESH:D003093 |
Colitis, Ulcerative |
|
phenethyl isothiocyanate |
3.62 | 20423518 |
MESH:D015179 |
Colorectal Neoplasms |
|
Azacitidine |
2.90 | 19934284 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.90 | 18802399 18259882 |
MESH:D003550 |
Cystic Fibrosis |
|
Acetylcysteine |
4.31 | 19747007 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.74 | 11906362 12868966 11298694 2524372 8970840 8156756 14531868 18759878 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.39 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.43 | 3621924 2952479 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.35 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
6.32 | 9328219 1440618 9022650 18289764 11289319 7440962 18648102 16192314 18692083 6679447 6482804 8291058 9653073 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetylcysteine |
6.32 | 11287661 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
6.32 | 17416283 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
13.71 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Lamivudine |
13.71 | 15040536 |
MESH:D004362 |
Drug Toxicity |
|
Zidovudine |
13.71 | 15040536 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.42 | 12083418 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
3.87 | 15138306 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
7.39 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
7.39 | 11473722 19148513 18566989 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.10 | 18037988 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.33 | 17637181 15821434 15328337 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.09 | 3581430 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
12.79 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
12.79 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Zidovudine |
12.79 | 18299183 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
3.95 | 9205823 11852909 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.96 | 6705139 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.53 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.08 | 12168785 12639820 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.16 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.31 | 17150277 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.97 | 7505956 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.48 | 15692506 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.44 | 16244372 16244371 18674790 16330681 14766674 16707910 16144979 17888722 16879835 12587719 17875725 18006777 16495754 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
6.91 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
6.91 | 20558911 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.84 | 15692506 |
MESH:D006402 |
Hematologic Diseases |
|
Zidovudine |
4.65 | 12579204 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.36 | 15720958 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.32 | 16366002 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.45 | 6705139 |
MESH:D006509 |
Hepatitis B |
|
Lamivudine |
5.04 | 17703166 |
MESH:D019694 |
Hepatitis B, Chronic |
|
Lamivudine |
5.04 | 12044531 16476009 15309715 15631357 15274664 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
2.93 | 19176532 18467677 19772884 16221962 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.98 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
Etoposide |
4.50 | 10809021 |
MESH:D015658 |
HIV Infections |
|
Lamivudine |
6.94 | 20032539 9296927 11141242 17530837 |
MESH:D015658 |
HIV Infections |
|
Zidovudine |
6.94 | 11141242 11363243 17358032 11698656 20032539 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
7.55 | 18501091 17606976 15147373 |
MESH:D006689 |
Hodgkin Disease |
|
Etoposide |
7.55 | 16135485 17606976 15147373 16200630 18180244 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.70 | 17088409 |
MESH:D006937 |
Hypercholesterolemia |
|
Cholesterol |
4.91 | 16933029 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.12 | 20558911 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.88 | 15034207 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.07 | 10903974 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
2.84 | 12878042 9205823 17237260 17255318 17963957 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
12.06 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
12.06 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
12.06 | 16306350 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.57 | 17255318 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.96 | 9022650 8074119 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.39 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
9.87 | 8314463 18776723 10903974 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
9.87 | 15369732 15699352 16775033 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
9.87 | 15618244 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.09 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
17.32 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
17.32 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
17.32 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Zidovudine |
17.32 | 12579204 |
MESH:D007859 |
Learning Disorders |
|
Cholesterol |
5.03 | 17134702 |
MESH:D007938 |
Leukemia |
|
Azacitidine |
3.66 | 19148494 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.10 | 16085563 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Zidovudine |
4.35 | 20370541 |
MESH:D007951 |
Leukemia, Myeloid |
|
Azacitidine |
4.56 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Azacitidine |
2.99 | 17596541 18720364 |
MESH:D054429 |
Leukemia, Myelomonocytic, Juvenile |
|
Azacitidine |
5.13 | 19299654 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.64 | 15821434 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.15 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
4.92 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
4.92 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
4.92 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
4.92 | 15474484 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
1.80 | 20007298 16377806 15890375 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
5.92 | 598648 6587162 1399818 3712494 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
5.92 | 16842330 17085340 |
MESH:D008171 |
Lung Diseases |
|
Acetylcysteine |
4.01 | 12815614 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
3.94 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
Azacitidine |
3.68 | 21224363 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
3.68 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Zidovudine |
3.68 | 18800350 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
7.75 | 16098063 |
MESH:D008223 |
Lymphoma |
|
Etoposide |
7.75 | 12556972 12854902 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.73 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.50 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
5.98 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
5.98 | 17203775 11408345 16891317 11807958 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.43 | 19453300 |
MESH:D008545 |
Melanoma |
|
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid |
4.01 | 17992120 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
4.01 | 16827129 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.03 | 17638057 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.73 | 16801185 |
MESH:D048629 |
Micronuclei, Chromosome-Defective |
|
Zidovudine |
5.78 | 17358032 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.44 | 15792986 |
MESH:D009006 |
Monosomy |
|
Azacitidine |
6.03 | 19299654 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.73 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
Azacitidine |
3.92 | 19549372 18443271 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.44 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Azacitidine |
3.96 | 17596541 18720364 17611569 19805378 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
5.62 | 15857846 19429709 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.62 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
8.08 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
8.08 | 16411023 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
9.50 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Acetylcysteine |
9.50 | 14720322 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
9.50 | 18259882 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
1.92 | 17405874 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.67 | 17289903 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.70 | 16636307 16899518 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.39 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
9.10 | 19348381 18481113 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
9.10 | 15640375 16889571 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
9.53 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
9.53 | 11399458 16427766 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
7.44 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
Acetylcysteine |
7.44 | 19446573 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
7.18 | 15555623 |
MESH:D009447 |
Neuroblastoma |
|
Topotecan |
7.18 | 15176712 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
Cholesterol |
5.64 | 20557099 9802331 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.80 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
3.36 | 6482804 4026338 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.96 | 3988306 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.06 | 15930896 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.93 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
2.20 | 19401270 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Etoposide |
3.25 | 19003803 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.42 | 7296757 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.41 | 6228378 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.10 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.10 | 17638057 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.49 | 11605937 12224865 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.16 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
3.89 | 10548101 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.72 | 15572423 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
10.35 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
10.35 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Azacitidine |
1.90 | 18324645 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
1.90 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
1.90 | 18247401 16289102 16644109 12479363 15754350 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
1.90 | 16868541 15897917 16888761 16729912 18437689 15749863 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
1.90 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Etoposide |
1.90 | 17172428 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.21 | 16882103 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.72 | 10548101 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.16 | 17922066 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.35 | 19058328 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Acetylcysteine |
4.46 | 12210543 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.69 | 10835634 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.32 | 3692021 |
MESH:D012206 |
Rhabdomyolysis |
|
Lamivudine |
5.47 | 9296927 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.93 | 17203757 15625365 18313854 17710206 15675481 16767912 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
10.34 | 16326096 14601052 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Etoposide |
10.34 | 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.73 | 17846226 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
5.82 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
5.82 | 8532709 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.50 | 15625365 17203757 16767912 |
MESH:D013274 |
Stomach Neoplasms |
|
Zidovudine |
2.47 | 17696246 |
MESH:D013276 |
Stomach Ulcer |
|
Acetylcysteine |
3.94 | 17918041 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.92 | 16684133 16045194 |
MESH:D013733 |
Testicular Diseases |
|
phenethyl isothiocyanate |
4.88 | 15864552 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
4.10 | 15821434 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
7.09 | 1399818 7505956 6587162 3712494 6582329 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
7.09 | 16010429 17909728 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.63 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
5.10 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
5.10 | 17653716 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.95 | 14652134 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.93 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Zidovudine |
4.69 | 12579204 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.16 | 17678736 17638931 16364871 17334414 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.39 | 17120751 |